Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$820,346
-$799,131 QoQ
Shares Held
25,684
-39.3% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#89
of 169 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PDT Partners, LLC holds $58,476,347 across 23 Biotechnology names. TYRA ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
122,041 | $14,287,339 | |
| 2 | RCUS |
Arcus Biosciences, Inc.
|
323,567 | $9,975,570 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
301,272 | $5,242,132 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
265,491 | $4,505,382 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
155,075 | $4,066,066 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
108,100 | $3,825,659 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
80,899 | $3,010,251 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
41,585 | $2,284,679 |
All Filings in TYRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $820,346 | 25,684 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,619,477 | 42,284 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,111,646 | 42,284 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $605,906 | 43,310 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $414,476 | 43,310 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $282,990 | 20,359 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $244,742 | 15,306 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $199,653 | 12,174 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||